Programme

Descargar PDFIBCG_2O18

 

 

✦ 9.00-09.30 CHECK IN

 

✦ 09.30-10.00 RECEPTION

              Beatriz Allegue, General Manager Axencia de Coñecemento en Saúde (ACIS)

              Luis Verde, General Manager Gerencia Gestión Integrada A Coruña

              Angélica Figueroa, Phd. Instituto de Investigación Biomédica de A Coruña – INIBIC

              Charo G. Campelo, MD. Hospital A Coruña INIBIC-CHUAC

              Luis León, Oncologist CHUS-IDIS

 

✦ 10.00-12.00 CANCER RESEARCH SESSION I:

 

Chair – Ángel Carracedo, MD, PhD. Fundación Pública Galega Medicina Genómica USC-FPGMX

 

⇒10.00-10.30  Charo G. Campelo, MD. Hospital A Coruña, INIBIC-CHUAC

Title: Immunotherapy and Cancer

⇒10.35-10.55  José Tubio, PhD. Grupo de Cáncer Transmisible, USC-CIMUS

Title: The driver role of transposable elements in cancer

⇒11.00-11.20  María de la Fuente, Nano-Oncology Unit, Head. Translational Medical Oncology Group                             (ONCOMET), IDIS.

Title: The pontential of Nanotechnology for the development of innovatice anticancer therapies

⇒11.25-11.45  Javier Robles, PhD. Centro Investigación del Cáncer (CIC, CSIC)

Title: A new tumor suppressor machanism in T cell acute lymphoblastic leukemia: VAV1 is not such a bad guy in cancer

       ⇒11.45-12.00  Ángel D.Lagares, PhD. Instituto de Investigación Sanitaria de Santiago de Compostela                                      (IDIS)

Title: Epigenetic biomarkers in precision oncology

 

✦12:00-12.30 COFFEE BREAK

 

✦12.30-14.30 CANCER RESEARCH SESSION II:

 

Chair – Mabel Loza, PhD. Grupo de investigación Biofarma (USC-CI)

 

⇒12.30-13.00  Joaquín Arribas, PhD. Vall d’Hebron Instituto de Oncología (VHIO)

Title: Novel strategies to treat breast cancers

⇒13.05-13.25  Ruth Muñóz Risueño, PhD. Instituto de Investigación contra la Leucemia Josep Carrera

Title: New therapeutic targets in Acute Myeloid Leukemia

⇒13.30-13.50  Germán Bou, MD, PhD. Hospital A Coruña, INIBIC-CHUAC

Title: Microbiome and cancer

⇒13.55-14.15  Ceres Fernández-Rozadilla. Grupo de Medicina Xenómica. Fundación Instituto de                                       Investigación Sanitaria de Santiago

Title: PanCanRisk: Personalized bioinformatics for global cancer susceptibility identification and clinical management

⇒14.20-14.30  Cristina Núñez, Principal Head Nanoproteomic Lab-HULA

Title: A novel quinoline molecular probe and the derived functionalized gold nanoparticles: Sensing properties and cytotoxicity studies in MCF-7 human breast cancer cells.

 

✦14.30-16.00 LUNCH, POSTERS and MEET THE EXPERT

 

✦16.00-17.00 EDUCATIONAL SESSION

 

Chair – Alejandro Pazos, PhD. Full Profesor, University A Coruña

 

⇒16.00-16.20  Angélica Figueroa, PhD. Instituto de Investigación Biomédica de A Coruña – INIBIC

Title: Building a successful career in cancer research

⇒16.20-16.30  Inés Martínez Pena, Unidad Mixta Roche-CHUS, ONCOMET, IDIS

Title: Development of in vitro CTC-cluster models and evaluation of their metastatic potential in breast cancer

⇒16.30-16.40  Mónica Martinez-Fernández, Mobile Genomes and Disease Lab. CIMUS -USC

Title: Detection of High Rates of Somatic Retrotransposition by Agilent SureSelect System in Lung Cancer

⇒16.40-16.50  Anabel Alba González Neurover, CICA, UCD

Title: Toxicity and cell cycle effects in zebrafish of various Ruthenium (II) compounds

⇒16.50-17.00  Sheila Barrios Esteban Nanobiofar Group – CIMUS

Title: Protamine:Dextran nanoparticles for the treatment of glioblastoma multiforme by gene therapy

 

✦17.00-17.30 AWARDS AND CLOSING

 

Angélica Figueroa, PhD. Instituto de Investigación Biomédica de A Coruña – INIBIC

Alejandro Pazos, PhD. Full Professor, University A Coruña